Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat

Y Dong, R Tu, H Liu, G Qing - Signal transduction and targeted therapy, 2020 - nature.com
Cancer cells must rewire cellular metabolism to satisfy the demands of unbridled growth and
proliferation. As such, most human cancers differ from normal counterpart tissues by a …

Targeting MYCN in Pediatric and Adult Cancers

Z Liu, SS Chen, S Clarke, V Veschi, CJ Thiele - Frontiers in Oncology, 2021 - frontiersin.org
The deregulation of the MYC family of oncogenes, including c-MYC, MYCN and MYCL
occurs in many types of cancers, and is frequently associated with a poor prognosis. The …

[HTML][HTML] PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression

M Liu, B Yao, T Gui, C Guo, X Wu, J Li, L Ma, Y Deng… - Theranostics, 2020 - ncbi.nlm.nih.gov
The proto-oncogene c-Myc regulates multiple biological processes mainly through
selectively activating gene expression. However, the mechanisms underlying c-Myc …

Myelocytomatosis‐protein arginine N‐Methyltransferase 5 Axis defines the tumorigenesis and immune response in hepatocellular carcinoma

Y Luo, Y Gao, W Liu, Y Yang, J Jiang, Y Wang… - …, 2021 - Wiley Online Library
Background and Aims HCC is a leading cause of cancer‐related deaths globally with poor
outcome and limited therapeutic options. Although the myelocytomatosis (MYC) oncogene is …

Subgroup-specific diagnostic, prognostic, and predictive markers influencing pediatric medulloblastoma treatment

S Ray, NK Chaturvedi, KK Bhakat, A Rizzino… - Diagnostics, 2021 - mdpi.com
Medulloblastoma (MB) is the most common malignant central nervous system tumor in
pediatric patients. Mainstay of therapy remains surgical resection followed by craniospinal …

Critical roles of protein arginine methylation in the central nervous system

K Chang, D Gao, J Yan, L Lin, T Cui, S Lu - Molecular Neurobiology, 2023 - Springer
A remarkable post-transitional modification of both histones and non-histone proteins is
arginine methylation. Methylation of arginine residues is crucial for a wide range of cellular …

PRMT5 as a potential therapeutic target in MYC-amplified medulloblastoma

D Kumar, S Jain, DW Coulter, SS Joshi, NK Chaturvedi - Cancers, 2023 - mdpi.com
Simple Summary Medulloblastoma is the most prevalent intracerebellar pediatric brain
tumor, accounting for approximately 20% of all childhood brain tumors and over 60% of …

Treatment of recurrent or metastatic adenoid cystic carcinoma

LG de Sousa, FL Neto, J Lin, R Ferrarotto - Current oncology reports, 2022 - Springer
Abstract Purpose of Review Adenoid cystic carcinoma (ACC) is a rare and heterogeneous
malignancy of secretory glands. Recurrence after curative-intent treatment is common, and …

Protein Arginine Methyltransferase 5 Functions via Interacting Proteins

Z Liang, C Wen, H Jiang, S Ma, X Liu - Frontiers in cell and …, 2021 - frontiersin.org
The protein arginine methyltransferases (PRMTs) are involved in such biological processes
as transcription regulation, DNA repair, RNA splicing, and signal transduction, etc. In this …

PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo

EJ Brown, L Balaguer-Lluna, AP Cribbs, M Philpott… - Scientific Reports, 2024 - nature.com
Abstract H3K27-altered Diffuse Midline Glioma (DMG) is a universally fatal paediatric
brainstem tumour. The prevalent driver mutation H3K27M creates a unique epigenetic …